Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Retinal diseases are the leading causes of blindness in Canada. Retinal diseases are currently treated by monthly or bimonthly intraocular injections of biologics. At the Sheardown lab, we are developing a new injectable hydrogel that can provide prolonged treatment for retinal diseases. Upon injection, the new treatment forms a transparent solid depot inside the eye that doesn’t interfere with the patient’s vision. The depot provides sustained release of the biologics over several months and is completely resorbable after delivery of its payload. The new treatment aims at reducing the frequency of intraocular injections to improve patient convenience and reduce the burden on ophthalmology clinics.
Heather Sheardown
Karim Soliman
Springboard Atlantic
Engineering - chemical / biological
Professional, scientific and technical services
McMaster University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.